New hope for Tough-to-Treat lung cancer: experimental drug enters human testing
NCT ID NCT05815160
Summary
This early-stage study is testing a new oral drug called Debio 0123, given alongside two standard chemotherapy drugs (carboplatin and etoposide), for adults whose small cell lung cancer has returned or worsened after initial platinum-based treatment. The main goals are to find a safe dose and see how well the body handles the combination. Researchers will also look for early signs that the treatment might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER RECURRENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Universidad de Navarra
Madrid, 28027, Spain
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Hospital Clinic Barcelona
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Quironsalud Malaga
Málaga, 29004, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario HM Sanchinarro. START Madrid - Centro Integral Oncológico Clara Campal (CIOCC)
Madrid, 28050, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario de A Coruna
A Coruña, 15006, Spain
-
Institut Catala D'Oncologia - Badalona
Barcelona, 08908, Spain
-
NEXT Oncology Madrid
Madrid, 28223, Spain
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.